- Home
- POAI vs HSCS Comparison
POAI vs HSCS Comparison
Compare POAI & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- HSCS
- Stock Information
- Founded
- POAI 2002
- HSCS 2007
- Country
- POAI United States
- HSCS United States
- Employees
- POAI N/A
- HSCS N/A
- Industry
- POAI Industrial Specialties
- HSCS Medical Specialities
- Sector
- POAI Health Care
- HSCS Health Care
- Exchange
- POAI Nasdaq
- HSCS Nasdaq
- Market Cap
- POAI 7.8M
- HSCS 8.7M
- IPO Year
- POAI N/A
- HSCS 2022
- Fundamental
- Price
- POAI $0.93
- HSCS $3.30
- Analyst Decision
- POAI Hold
- HSCS Strong Buy
- Analyst Count
- POAI 1
- HSCS 2
- Target Price
- POAI N/A
- HSCS $13.00
- AVG Volume (30 Days)
- POAI 122.8K
- HSCS 84.7K
- Earning Date
- POAI 11-11-2025
- HSCS 09-11-2025
- Dividend Yield
- POAI N/A
- HSCS N/A
- EPS Growth
- POAI N/A
- HSCS N/A
- EPS
- POAI N/A
- HSCS N/A
- Revenue
- POAI $1,664,696.00
- HSCS $6,250.00
- Revenue This Year
- POAI $486.27
- HSCS $13,968.97
- Revenue Next Year
- POAI $65.50
- HSCS $166.67
- P/E Ratio
- POAI N/A
- HSCS N/A
- Revenue Growth
- POAI 71.65
- HSCS N/A
- 52 Week Low
- POAI $0.55
- HSCS $2.52
- 52 Week High
- POAI $3.06
- HSCS $6.47
- Technical
- Relative Strength Index (RSI)
- POAI 55.05
- HSCS 46.13
- Support Level
- POAI $0.90
- HSCS $3.00
- Resistance Level
- POAI $1.08
- HSCS $3.49
- Average True Range (ATR)
- POAI 0.07
- HSCS 0.19
- MACD
- POAI 0.00
- HSCS -0.01
- Stochastic Oscillator
- POAI 36.09
- HSCS 50.85
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.